Recombinant multi-species TXNIP/VDUP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TXNIP/VDUP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a thioredoxin-binding protein that is a member of the alpha arrestin protein family. Thioredoxin is a thiol-oxidoreductase that is a major regulator of cellular redox signaling which protects cells from oxidative stress. This protein inhibits the antioxidative function of thioredoxin resulting in the accumulation of reactive oxygen species and cellular stress. This protein also functions as a regulator of cellular metabolism and of endoplasmic reticulum (ER) stress. This protein may also function as a tumor suppressor. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
The Alternative Names of target: 1200008J08Rik,ARRDC6,EST01027,HHCPA78,Hyplip1,THIF,TXNIP,Tbp-2,Thioredoxin-binding protein 2,Thioredoxin-interacting protein,Txnip,VDUP1,Vdup1,Vitamin D3 up-regulated protein 1

Target products collectionGo to TXNIP/VDUP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0163-Ag-1/ GM-Tg-hg-IP0163-Ag-2 Human TXNIP/VDUP1 protein Human
GM-Tg-rg-IP0163-Ag-1/ GM-Tg-rg-IP0163-Ag-2 Rat TXNIP/VDUP1 protein Rat
GM-Tg-mg-IP0163-Ag-1/ GM-Tg-mg-IP0163-Ag-2 Mouse TXNIP/VDUP1 protein Mouse
GM-Tg-cynog-IP0163-Ag-1/ GM-Tg-cynog-IP0163-Ag-2 Cynomolgus/Rhesus macaque TXNIP/VDUP1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0163-Ag-1/ GM-Tg-felg-IP0163-Ag-2 Feline TXNIP/VDUP1 protein Feline
GM-Tg-cang-IP0163-Ag-1/ GM-Tg-cang-IP0163-Ag-2 Canine TXNIP/VDUP1 protein Canine
GM-Tg-bovg-IP0163-Ag-1/ GM-Tg-bovg-IP0163-Ag-2 Bovine TXNIP/VDUP1 protein Bovine
GM-Tg-equg-IP0163-Ag-1/ GM-Tg-equg-IP0163-Ag-2 Equine TXNIP/VDUP1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0163-Ag-1/ GM-Tg-hg-IP0163-Ag-2; GM-Tg-rg-IP0163-Ag-1/ GM-Tg-rg-IP0163-Ag-2;
GM-Tg-mg-IP0163-Ag-1/ GM-Tg-mg-IP0163-Ag-2; GM-Tg-cynog-IP0163-Ag-1/ GM-Tg-cynog-IP0163-Ag-2;
GM-Tg-felg-IP0163-Ag-1/ GM-Tg-felg-IP0163-Ag-2; GM-Tg-cang-IP0163-Ag-1/ GM-Tg-cang-IP0163-Ag-2;
GM-Tg-bovg-IP0163-Ag-1/ GM-Tg-bovg-IP0163-Ag-2; GM-Tg-equg-IP0163-Ag-1/ GM-Tg-equg-IP0163-Ag-2
Products Name TXNIP/VDUP1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name TXNIP/VDUP1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TXNIP/VDUP1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.